|1.||Schito, G C: 1 article (07/2007)|
|2.||Serra, A: 1 article (07/2007)|
|3.||Fadda, G: 1 article (07/2007)|
|4.||Nicoletti, G: 1 article (07/2007)|
|5.||Todisco, C: 1 article (06/2002)|
|6.||Todisco, T: 1 article (06/2002)|
|7.||Baglioni, S: 1 article (06/2002)|
|8.||Eslami, A: 1 article (06/2002)|
|9.||Mombelli, B: 1 article (07/2000)|
|10.||Gismondo, M R: 1 article (07/2000)|
07/01/1999 - "To assess the efficacy of aerosolized TGA in the treatment of experimental pneumonia in mice, we compared its in vivo activity with that of thiamphenicol glycinate hydrochloride (TG), erythromycin (ERT) and amoxicillin (AMX), the last two compounds being more active in vitro than TAP. "
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
07/01/2000 - "Thiamphenicol glycinate (TG) and its derivative thiamphenicol glycinate N-acetylcysteinate (TGA) could be a valid therapeutic option in the treatment of respiratory tract infections. "
07/01/2007 - "Eight hundred and seventeen patients with upper respiratory tract infections were treated with thiamphenicol glycinate acetylcisteinate (TGA) or other standard antibiotics for 6-10 days in a randomised trial. "
06/01/2002 - "An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae."
|3.||Renal Insufficiency (Renal Failure)
|4.||Whooping Cough (Pertussis)
|5.||Lung Diseases (Lung Disease)
|3.||Anti-Bacterial Agents (Antibiotics)